{"id":60776,"date":"2024-02-28T07:07:41","date_gmt":"2024-02-28T07:07:41","guid":{"rendered":"https:\/\/medsname.com\/tenvir-af\/"},"modified":"2026-05-21T05:27:39","modified_gmt":"2026-05-21T05:27:39","slug":"tenvir-af","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/tenvir-af\/","title":{"rendered":"Tenvir AF"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:16px 20px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin-top:0;\">Gyors v\u00e1lasz \u2013 Tenvir AF (Tenofovir Alafenamide 25 mg)<\/h3>\n<ul>\n<li><strong>Hat\u00f3anyag:<\/strong> tenofovir alafenamide fumarate (TAF) 25 mg, sz\u00e1jon \u00e1t szedhet\u0151 tabletta, naponta egyszer \u00e9tkez\u00e9ssel egy\u00fctt.<\/li>\n<li><strong>Els\u0151dleges indik\u00e1ci\u00f3 ezen a list\u00e1n:<\/strong> kr\u00f3nikus hepatitis B v\u00edrus (HBV) fert\u0151z\u00e9s feln\u0151ttekben \u2014 hossz\u00fa t\u00e1v\u00fa g\u00e1tl\u00e1s jelent\u0151sen kevesebb vese- \u00e9s csontkitetts\u00e9ggel, mint a r\u00e9gebbi TDF.<\/li>\n<li><strong>Mechanism:<\/strong> nukleotid reverz transzkript\u00e1z g\u00e1tl\u00f3 (NRTI). Ugyanaz az akt\u00edv metabolit, mint a tenofovir diszoproxil, de egy m\u00e1sik el\u0151gy\u00f3gyszer, amely a tenofovirt a hepatocyt\u00e1kban \u00e9s limfocit\u00e1kban szabad\u00edtja fel.<\/li>\n<li><strong>TDF-hez k\u00e9pest:<\/strong> ~90%-kal alacsonyabb plazma tenofovir szint, ~6\u20137-szer magasabb intracellul\u00e1ris gy\u00f3gyszerkoncentr\u00e1ci\u00f3. Ugyanaz a v\u00edrusellenes hat\u00e9konys\u00e1g. Alacsonyabb a vesetoxicit\u00e1s \u00e9s a csonts\u0171r\u0171s\u00e9g-cs\u00f6kken\u00e9s kock\u00e1zata.<\/li>\n<li><strong>HBV hat\u00e9konys\u00e1g:<\/strong> nem alulm\u00falja a TDF-t a HBV DNS g\u00e1tl\u00e1s szempontj\u00e1b\u00f3l 96 h\u00e9t ut\u00e1n; szignifik\u00e1nsan jobb vese- \u00e9s csontbiztons\u00e1gi markerek a k\u00f6zvetlen \u00f6sszehasonl\u00edt\u00f3 vizsg\u00e1latokban.<\/li>\n<li><strong>HBV fell\u00e1ngol\u00e1s figyelmeztet\u00e9s:<\/strong> s\u00falyos akut fell\u00e1ngol\u00e1s fordulhat el\u0151 a kezel\u00e9s megszak\u00edt\u00e1sakor. Soha ne szak\u00edtsa meg szakember fel\u00fcgyelete n\u00e9lk\u00fcl.<\/li>\n<\/ul>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<h3>Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n<h2 class=\"wp-block-heading\">Mi az Tenvir AF?<\/h2>\n<p>A Tenvir AF egy tabletta form\u00e1j\u00fa k\u00e9sz\u00edtm\u00e9ny, amely <strong>tenofovir alafenamid fumar\u00e1t 25 mg-ot<\/strong> (TAF) tartalmaz, a Cipla gy\u00e1rtja. Minden csomag \u00e1ltal\u00e1ban 30 filmbevonatos tablett\u00e1t tartalmaz.<\/p>\n<p>A TAF a tenofovir m\u00e1sodik gener\u00e1ci\u00f3s el\u0151gy\u00f3gyszere, amelyet a r\u00e9gebbi TDF (tenofovir diszoproxil) el\u0151gy\u00f3gyszer okozta vese- \u00e9s csonttoxicit\u00e1si probl\u00e9m\u00e1k kik\u00fcsz\u00f6b\u00f6l\u00e9s\u00e9re terveztek. Az eredeti m\u00e1rka a <strong>Vemlidy<\/strong> (Gilead, FDA \u00e1ltal j\u00f3v\u00e1hagyva kr\u00f3nikus hepatitis B kezel\u00e9s\u00e9re 2016-ban). Ugyanaz az akt\u00edv hat\u00f3anyag, mint a TDF-ben, dr\u00e1maian elt\u00e9r\u0151 farmakokinetikai tulajdons\u00e1gokkal.<\/p>\n<h2 class=\"wp-block-heading\">Mire haszn\u00e1lj\u00e1k a Tenvir AF-et?<\/h2>\n<ul>\n<li><strong>Kr\u00f3nikus hepatitis B (CHB) kezel\u00e9s\u00e9re feln\u0151ttekben<\/strong> \u2014 els\u0151 vonalbeli or\u00e1lis antivir\u00e1lis szer, k\u00fcl\u00f6n\u00f6sen kr\u00f3nikus vesebetegs\u00e9gben (CKD), osteopor\u00f3zisban szenved\u0151, 60 \u00e9v feletti vagy TDF-hez kapcsol\u00f3d\u00f3 vese-\/csonttoxicit\u00e1sban szenved\u0151 betegek eset\u00e9n.<\/li>\n<li><strong>HIV-1 fert\u0151z\u00e9s eset\u00e9n<\/strong> \u2014 kombin\u00e1ci\u00f3s kezel\u00e9sek r\u00e9sze (leggyakrabban FTC-vel, dolutegravirral vagy bictegravirral, vagy rilpivirinnel kombin\u00e1lva). Nem haszn\u00e1lhat\u00f3 monoter\u00e1piak\u00e9nt HIV-fert\u0151z\u00e9s kezel\u00e9s\u00e9re.<\/li>\n<li><strong>HIV megel\u0151z\u0151 profilaxis (PrEP)<\/strong> \u2014 a TAF + emtricitabin kombin\u00e1ci\u00f3 (Descovy) j\u00f3v\u00e1hagyott PrEP-re cisznem\u0171 f\u00e9rfiak \u00e9s transznem\u0171 n\u0151k eset\u00e9n; a TDF\/FTC marad az el\u0151nyben r\u00e9szes\u00edtett v\u00e1laszt\u00e1s terhess\u00e9 v\u00e1l\u00e1sra hajlamos, kock\u00e1zatnak kitett szem\u00e9lyekn\u00e9l.<\/li>\n<\/ul>\n<p>A TAF <strong>nem<\/strong> nem haszn\u00e1lhat\u00f3 hepatitis C, herpeszv\u00edrus vagy b\u00e1rmilyen nem retrovir\u00e1lis \/ nem HBV fert\u0151z\u00e9s kezel\u00e9s\u00e9re.<\/p>\n<h2 class=\"wp-block-heading\">Mi\u00e9rt TAF a TDF helyett?<\/h2>\n<p>A TDF gyorsan hidroliz\u00e1l\u00f3dik a plazm\u00e1ban tenofovirr\u00e1, \u00edgy a ves\u00e9ket \u00f3r\u00e1kig magas kering\u0151 gy\u00f3gyszerszintnek teszi ki. A TAF sokkal tov\u00e1bb marad \u00e9rintetlen a plazm\u00e1ban, mivel stabilabb el\u0151gy\u00f3gyszer, \u00e9s a limfocit\u00e1k \u00e9s hepatocit\u00e1k intracellul\u00e1ris \u00e9szter\u00e1zai (katepsin A, CES1) r\u00e9szes\u00edtik el\u0151nyben. V\u00e9geredm\u00e9ny:<\/p>\n<table style=\"border-collapse:collapse;width:100%;font-size:14px;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;border:1px solid #ddd;text-align:left;\">Jelz\u0151<\/th>\n<th style=\"padding:8px;border:1px solid #ddd;text-align:left;\">TDF 300 mg<\/th>\n<th style=\"padding:8px;border:1px solid #ddd;text-align:left;\">TAF 25 mg<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Plasma tenofovir AUC<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Magas (referencia)<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">~90%-kal alacsonyabb<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">Intracellul\u00e1ris TFV-DP PBMC-kben<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Referencia<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">~6\u20137\u00d7 magasabb<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">eGFR-cs\u00f6kken\u00e9s 96 h\u00e9t ut\u00e1n (HBV)<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">M\u00e9rs\u00e9kelt, d\u00f3zisf\u00fcgg\u0151<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Jelent\u0151sen kevesebb<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">Cs\u00edp\u0151 \u00e9s gerinc BMD-v\u00e1ltoz\u00e1s<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Kism\u00e9rt\u00e9k\u0171 cs\u00f6kken\u00e9s<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Kisebb cs\u00f6kken\u00e9s; n\u00e9ha helyre\u00e1ll\u00e1s v\u00e1lt\u00e1skor<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Lipidhat\u00e1s<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Enyh\u00e9n kedvez\u0151 (lipidcs\u00f6kkent\u0151)<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Enyh\u00e9n kedvez\u0151tlen (n\u00f6veli az LDL\/HDL ar\u00e1nyt)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>A lipidhat\u00e1s az egyetlen kompromisszum. Sz\u00edv- \u00e9s \u00e9rrendszeri betegs\u00e9gben szenved\u0151 betegekn\u00e9l a TDF lehet el\u0151ny\u00f6sebb. A legt\u00f6bb HBV-s betegn\u00e9l vesebetegs\u00e9g vagy csontrizik\u00f3 eset\u00e9n a TAF a tiszt\u00e1bb hossz\u00fa t\u00e1v\u00fa megold\u00e1s.<\/p>\n<h2 class=\"wp-block-heading\">Adagol\u00e1s \u00e9s szed\u00e9si m\u00f3d Tenvir AF eset\u00e9n<\/h2>\n<ul>\n<li><strong>Kr\u00f3nikus hepatitis B:<\/strong> napi egyszer egy 25 mg-os tabletta \u00e9tkez\u00e9ssel egy\u00fctt.<\/li>\n<li><strong>HIV (kombin\u00e1ci\u00f3s kezel\u00e9sek):<\/strong> 25 mg, ha nem er\u0151s\u00edtett szerekkel kombin\u00e1lj\u00e1k; 10 mg, ha CYP3A g\u00e1tl\u00f3val (kobicisztat, ritonav\u00edr) egy\u00fctt adj\u00e1k.<\/li>\n<\/ul>\n<p>\u00c9tkez\u00e9ssel egy\u00fctt szedend\u0151 \u2014 a biohasznosul\u00e1s kb. 65%-kal n\u0151 m\u00e9rs\u00e9kelt zs\u00edrtartalm\u00fa \u00e9tkez\u00e9s mellett. Eg\u00e9szben nyelje le. Elfelejtett adag: szedje be, amint esz\u00e9be jut, ha 18 \u00f3r\u00e1n bel\u00fcl van; egy\u00e9bk\u00e9nt hagyja ki \u00e9s folytassa a k\u00f6vetkez\u0151 tervezett tablett\u00e1val.<\/p>\n<p><strong>D\u00f3zis\u00e1ll\u00edt\u00e1s veseel\u00e9gtelens\u00e9g eset\u00e9n:<\/strong> nincs sz\u00fcks\u00e9g \u00e1ll\u00edt\u00e1sra, ha CrCl \u2265 15 mL\/perc. 15 mL\/perc alatt csak kr\u00f3nikus hemodial\u00edzisben r\u00e9szes\u00fcl\u0151 betegekn\u00e9l haszn\u00e1lhat\u00f3 (TAF ad\u00e1sa dial\u00edzis ut\u00e1n a dial\u00edzis napj\u00e1n). TAF nem aj\u00e1nlott nem dializ\u00e1lt v\u00e9gst\u00e1dium\u00fa veseel\u00e9gtelens\u00e9gben.<\/p>\n<p><strong>M\u00e1jk\u00e1rosod\u00e1s:<\/strong> nincs sz\u00fcks\u00e9g \u00e1ll\u00edt\u00e1sra enyhe vagy k\u00f6zepes esetben; nem aj\u00e1nlott dekompenz\u00e1lt cirrhosisban (Child-Pugh C).<\/p>\n<h2 class=\"wp-block-heading\">Mell\u00e9khat\u00e1sok<\/h2>\n<p><strong>Gyakori:<\/strong> fejf\u00e1j\u00e1s (~10%), hasi f\u00e1jdalom (~5%), f\u00e1radts\u00e1g, k\u00f6h\u00f6g\u00e9s, h\u00e1nyinger, h\u00e1tf\u00e1j\u00e1s. \u00c1ltal\u00e1ban enyhe \u00e9s \u00f6nkorl\u00e1toz\u00f3.<\/p>\n<p><strong>Kevesebb gyakori, de fontos:<\/strong><\/p>\n<ul>\n<li><strong>Lipidv\u00e1ltoz\u00e1sok<\/strong> \u2014 v\u00e1rhat\u00f3 enyhe emelked\u00e9s LDL-C, HDL-C, teljes koleszterin \u00e9s triglicerid szintj\u00e9ben. Ellen\u0151rizze a lipid\u00e9rt\u00e9keket 3 \u00e9s 12 h\u00f3nap ut\u00e1n. Fontolja meg sztatinkezel\u00e9st, ha a kardiovaszkul\u00e1ris kock\u00e1zat magas.<\/li>\n<li><strong>S\u00falygyarapod\u00e1s<\/strong> \u2014 HIV vizsg\u00e1latok t\u00f6bb kg s\u00falygyarapod\u00e1st mutattak 1\u20132 \u00e9v alatt TAF-t tartalmaz\u00f3 kezel\u00e9sekn\u00e9l a TDF-hez k\u00e9pest (a TDF enyhe lipidcs\u00f6kkent\u0151 hat\u00e1s\u00e1nak visszafejl\u0151d\u00e9se r\u00e9szben magyar\u00e1zhatja ezt). Kev\u00e9sb\u00e9 egy\u00e9rtelm\u0171 HBV monoter\u00e1pi\u00e1ban.<\/li>\n<li><strong>Laktacid\u00f3zis s\u00falyos hepatomeg\u00e1li\u00e1val<\/strong> \u2014 ritka NRTI oszt\u00e1lyhat\u00e1s; sz\u00fcntesse meg, ha magyar\u00e1zatlan progressz\u00edv hasi f\u00e1jdalom, gyors l\u00e9gz\u00e9s vagy s\u00falyos f\u00e1radts\u00e1g l\u00e9p fel.<\/li>\n<li><strong>S\u00falyos akut hepatitis B fell\u00e1ngol\u00e1s a kezel\u00e9s abbahagy\u00e1sakor<\/strong> \u2014 ugyanolyan fell\u00e1ngol\u00e1si kock\u00e1zat, mint a TDF eset\u00e9ben. Legal\u00e1bb 6 h\u00f3napig sz\u00fcks\u00e9ges monitoroz\u00e1s a kezel\u00e9s megszak\u00edt\u00e1sa ut\u00e1n.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/h2>\n<ul>\n<li><strong>Er\u0151s P-gp induk\u00e1l\u00f3k<\/strong> \u2014 rifampicin, rifabutin, karbamazepin, fenitoin, oxkarbazepin, Szent J\u00e1nos-keny\u00e9r \u2014 cs\u00f6kkentik a TAF expoz\u00edci\u00f3t. Ker\u00fclj\u00e9k a egy\u00fcttes alkalmaz\u00e1s\u00e1t.<\/li>\n<li><strong>CYP3A g\u00e1tl\u00f3k<\/strong> \u2014 kobicisztat, ritonav\u00edr \u2014 jelent\u0151sen n\u00f6velik a TAF expoz\u00edci\u00f3t. Haszn\u00e1lja a 10 mg-os form\u00e1t, ha egy\u00fctt alkalmaznak boosterelt PI\/INSTI rezsimmel.<\/li>\n<li><strong>Egy\u00e9b nephrotoxikus gy\u00f3gyszerek<\/strong> \u2014 kev\u00e9sb\u00e9 aggodalomra okot ad, mint a TDF eset\u00e9ben, de \u00f3vatoss\u00e1g m\u00e9g mindig javasolt cidofovirral, intrav\u00e9n\u00e1s aminoglikozidokkal, intrav\u00e9n\u00e1s amfotericin B-vel, magas d\u00f3zis\u00fa NSAID-okkal.<\/li>\n<li><strong>Egy\u00e9b tenofovirt tartalmaz\u00f3 term\u00e9kek<\/strong> \u2014 ne kombin\u00e1lja a TAF-et TDF-fel, adefovirral vagy m\u00e1s TAF-tartalm\u00fa term\u00e9kkel.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kik nem vehetik be a Tenvir AF-et?<\/h2>\n<ul>\n<li>Known hypersensitivity to tenofovir alafenamide or any excipient<\/li>\n<li>Severe renal impairment (CrCl &lt; 15 mL\/min) not on chronic haemodialysis<\/li>\n<li>Decompensated cirrhosis (Child-Pugh C)<\/li>\n<li>Concurrent strong P-gp inducer where switching is not feasible<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">T\u00e1rol\u00e1s<\/h2>\n<p>Store below 30\u00b0C in the original bottle with desiccant. Protect from moisture. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3 class=\"wp-block-heading\">Is Tenvir AF the same as Vemlidy?<\/h3>\n<p>Yes \u2014 same molecule (tenofovir alafenamide 25 mg), same indication (chronic hepatitis B), same once-daily dosing. Tenvir AF is Cipla\u2019s licensed generic version. Vemlidy is the originator (Gilead).<\/p>\n<h3 class=\"wp-block-heading\">If TAF is better, why does anyone still take TDF?<\/h3>\n<p>Several reasons: TDF has a 20-year safety database; TDF lowers LDL cholesterol slightly (TAF does the opposite); pregnancy data is more mature for TDF; and TDF is materially cheaper. For young patients without renal or bone issues, TDF remains a perfectly reasonable first-line choice. TAF is preferred when renal or bone safety matters most.<\/p>\n<h3 class=\"wp-block-heading\">Can I switch from Tenvir (TDF) to Tenvir AF?<\/h3>\n<p>Yes, and many patients do, especially after years on TDF when small declines in eGFR or BMD become relevant. The switch is straightforward: stop TDF, start TAF the next day. Antiviral suppression is maintained because both deliver the same active metabolite. Renal markers usually improve within 3\u20136 months. Recheck eGFR, urine protein, phosphate at 3 months post-switch.<\/p>\n<h3 class=\"wp-block-heading\">Will Tenvir AF cure my hepatitis B?<\/h3>\n<p>No oral antiviral cures HBV. Tenofovir alafenamide suppresses replication so completely that viral DNA usually becomes undetectable and liver inflammation resolves \u2014 but the cccDNA template inside hepatocytes is not eliminated. Around 1\u20133% of patients per year achieve functional cure (HBsAg loss). For most patients, treatment is long-term.<\/p>\n<h3 class=\"wp-block-heading\">Should I expect weight gain on Tenvir AF?<\/h3>\n<p>HIV combination data show modest weight gain on TAF regimens vs TDF, of around 2\u20134 kg over 96 weeks. The effect is smaller in HBV monotherapy and is partly explained by reversal of TDF\u2019s slight metabolic disadvantage. If weight gain is concerning, baseline lipid and glucose monitoring is reasonable.<\/p>\n<h3 class=\"wp-block-heading\">Fogyaszthatom a Tenvir AF-et terhess\u00e9g alatt?<\/h3>\n<p>A TAF terhess\u00e9gi adatai b\u0151v\u00fclnek, de m\u00e9g mindig kev\u00e9sb\u00e9 kiforrottak, mint a TDF eset\u00e9ben. A HBV kezel\u00e9s\u00e9re a terhess\u00e9g k\u00e9s\u0151i szakasz\u00e1ban (28. h\u00e9tt\u0151l) a vertik\u00e1lis transzmisszi\u00f3 megel\u0151z\u00e9s\u00e9re a TDF az el\u0151ny\u00f6sebb v\u00e1laszt\u00e1s a nagyobb biztons\u00e1gi adatb\u00e1zis alapj\u00e1n. Ha TAF-en stabil vagy \u00e9s terhes leszel, besz\u00e9lj a hepatol\u00f3gusoddal a v\u00e1lt\u00e1s el\u0151tt \u2014 a d\u00f6nt\u00e9s a v\u00edrus terhel\u00e9st\u0151l, a fibrosis st\u00e1diumt\u00f3l \u00e9s a trimesztert\u0151l f\u00fcgg.<\/p>\n<h3 class=\"wp-block-heading\">Hat a Tenvir AF HIV-rezisztencia mut\u00e1ci\u00f3kra?<\/h3>\n<p>A TAF \u00e9s a TDF rezisztenciaprofilja azonos, mivel ugyanazt az akt\u00edv metabolitot sz\u00e1ll\u00edtj\u00e1k. Mindkett\u0151 akt\u00edv marad a legt\u00f6bb timidin-anal\u00f3g mut\u00e1ci\u00f3val (TAM) szemben, de cs\u00f6kkent hat\u00e9konys\u00e1g\u00fa a K65R reverz transzkript\u00e1z mut\u00e1ci\u00f3val szemben. Rezisztenciavizsg\u00e1latnak kell ir\u00e1ny\u00edtania a kezel\u00e9si v\u00e1laszt\u00e1st, ha el\u00e9rhet\u0151.<\/p>\n<h3 class=\"wp-block-heading\">Sz\u00fcks\u00e9gesek v\u00e9rvizsg\u00e1latok a Tenvir AF kezd\u00e9se el\u0151tt?<\/h3>\n<p>Igen \u2014 alap HBV DNS, HBeAg \/ anti-HBe, HBsAg, ALT\/AST, teljes v\u00e9rk\u00e9p, eGFR, vizeletvizsg\u00e1lat (proteinuria), sz\u00e9rumfoszf\u00e1t, lipid panel \u00e9s HIV antitest\/antig\u00e9n teszt. A kezel\u00e9s monitoroz\u00e1sa ezut\u00e1n stabil betegekn\u00e9l 3\u20136 havonta t\u00f6rt\u00e9nik.<\/p>\n<h3 class=\"wp-block-heading\">L\u00e9p k\u00f6lcs\u00f6nhat\u00e1sba a Tenvir AF sztatinokkal, v\u00e9rnyom\u00e1scs\u00f6kkent\u0151kkel vagy fogamz\u00e1sg\u00e1tl\u00e1ssal?<\/h3>\n<p>Nincs klinikailag jelent\u0151s k\u00f6lcs\u00f6nhat\u00e1s sztatinokkal, ACE-g\u00e1tl\u00f3kkal, ARB-kkal, b\u00e9ta-blokkol\u00f3kkal, kalciumcsatorna-g\u00e1tl\u00f3kkal vagy hormon\u00e1lis fogamz\u00e1sg\u00e1tl\u00e1ssal. A kev\u00e9s val\u00f3di k\u00f6lcs\u00f6nhat\u00e1s er\u0151s P-gp induk\u00e1l\u00f3kkal (rifampicin, antikonvulz\u00e1nsok) \u00e9s CYP3A fokoz\u00f3kkal (kobicisztat, ritonavir) van.<\/p>\n<h3 class=\"wp-block-heading\">Hol rendelhetek Tenvir AF-et?<\/h3>\n<p>A Tenvir AF-et k\u00f6zvetlen\u00fcl rendelheted a MedsBase-t\u0151l. Eredeti Cipla k\u00e9szletet sz\u00e1ll\u00edtunk vil\u00e1gszerte. A kr\u00f3nikus hepatitis B kezel\u00e9s\u00e9t hepatol\u00f3gus vagy gasztroenterol\u00f3gus fel\u00fcgyelete mellett kell v\u00e9gezni, HBV DNS, ALT, eGFR \u00e9s HBsAg\/anti-HBs monitoroz\u00e1ssal megfelel\u0151 id\u0151k\u00f6z\u00f6nk\u00e9nt.<\/p>\n<h2 class=\"wp-block-heading\">Jogi nyilatkozat<\/h2>\n<p>Az oldalon tal\u00e1lhat\u00f3 inform\u00e1ci\u00f3k oktat\u00e1si c\u00e9lokat szolg\u00e1lnak, \u00e9s nem helyettes\u00edtik a szakorvosi tan\u00e1csot. A kr\u00f3nikus hepatitis B \u00e9s HIV kezel\u00e9se alapvizsg\u00e1latot, folyamatos szakorvosi monitoroz\u00e1st \u00e9s egy\u00e9ni kezel\u00e9si v\u00e1laszt\u00e1st ig\u00e9nyel. Ne kezdj el, hagyd abba vagy v\u00e1lts tenofovir alap\u00fa ter\u00e1pi\u00e1t min\u0151s\u00edtett klinikus konzult\u00e1ci\u00f3ja n\u00e9lk\u00fcl.<\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-prep-starter-pack\">A Tenvir-AF (TAF\/FTC) HIV PrEP kezel\u00e9sre alkalmas, de nem fed le bakteri\u00e1lis nemi \u00faton terjed\u0151 betegs\u00e9geket; ha r\u00e9tegzett v\u00e9delemre van sz\u00fcks\u00e9ged, sok felhaszn\u00e1l\u00f3 p\u00e1ros\u00edtja doxy-PEP-pel \u2014 a <a href='\/hu\/prep-starter-pack\/'>PrEP kezd\u0151csomagunkat (Tenvir-EM + doxiciklin 100 mg)<\/a> a bev\u00e1lt TDF\/FTC PrEP kezel\u00e9si rendszert doxiciklinnal kombin\u00e1lja szifilisz, klam\u00eddia \u00e9s gonorrhoea megel\u0151z\u00e9s\u00e9re.<\/p>\n<p class=\"medsbase-link-boost-2026-05-08\" data-marker=\"mb-link-boost-tenvir-em\">A betegek <a href=\"https:\/\/medsbase.com\/hu\/tenvir-af\/\">Tenvir AF<\/a> a hepatitis B-ben szenved\u0151k, akiknek HIV pre-expoz\u00edci\u00f3s profilaxisra is sz\u00fcks\u00e9g\u00fck van, vegy\u00e9k figyelembe, hogy <a href=\"https:\/\/medsbase.com\/hu\/tenvir-em\/\">Tenvir EM (tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg)<\/a> a j\u00f3v\u00e1hagyott kett\u0151s komponens\u0171 PrEP kezel\u00e9si rendszer, amely TDF-et kombin\u00e1l emtricitabinnel \u00e1tfog\u00f3 HIV megel\u0151z\u00e9s \u00e9rdek\u00e9ben.<\/p>\n<p class=\"medsbase-link-boost-2026-05-10\" data-marker=\"mb-link-boost-avonza\">Klinik\u00e1k, amelyek ART gy\u00f3gyszerlist\u00e1kat \u00e9p\u00edtenek k\u00f6r\u00e9 <a href=\"https:\/\/medsbase.com\/hu\/tenvir-af\/\">Tenvir AF (tenofovir alafenamid 25 mg)<\/a> mint vesek\u00edm\u00e9l\u0151 alapkezel\u00e9s, tov\u00e1bb\u00e1 rakt\u00e1roznak <a href=\"https:\/\/medsbase.com\/hu\/avonza\/\">Avonza (TDF\/lamivudin\/efavirenz)<\/a> k\u00f6lts\u00e9gtudatos betegek sz\u00e1m\u00e1ra, akikn\u00e9l a r\u00e9gebbi TDF formul\u00e1ci\u00f3 vesek\u00e1ros\u00edt\u00f3 hat\u00e1sa klinikailag elfogadhat\u00f3.<\/p>\n<p class=\"medsbase-link-boost-2026-05-21\" data-marker=\"mb-link-boost-tavin-em\">A betegek, akik j\u00f3l toler\u00e1lj\u00e1k <a href=\"https:\/\/medsbase.com\/hu\/tenvir-af\/\">Tenvir AF (tenofovir alafenamid 25 mg)<\/a> de alacsonyabb k\u00f6lts\u00e9g\u0171 napi PrEP lehet\u0151s\u00e9get keresnek a TAF\/FTC pr\u00e9mium n\u00e9lk\u00fcl, fontol\u00f3ra vehetik <a href=\"https:\/\/medsbase.com\/hu\/tavin-em\/\">A Tavin EM (tenofovir diszoproxil 300 mg + emtricitabin 200 mg)<\/a>, a r\u00e9gebbi TDF\/FTC PrEP alapkezel\u00e9st, amelynek a legnagyobb az evidenci\u00e1ja.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k<\/h3>\n<p>Egy\u00e9b term\u00e9kek a <strong>Kr\u00f3nikus betegs\u00e9gek<\/strong> v\u00e1s\u00e1rl\u00f3k \u00e1ltal szint\u00e9n megtekintett term\u00e9kek:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/ebasil\/\">Ebasil<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/budecort-inhaler\/\">Budecort Inhaler<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/fluvoxin\/\">Fluvoxin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/arkamin-h\/\">Arkamin-H<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/ivepred\/\">Ivepred<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 HIV-fert\u0151z\u00e9s kezel\u00e9se<br \/>\n\u2705 Cs\u00f6kkenti a v\u00edrusterhel\u00e9st<br \/>\n\u2705 V\u00e9di a ves\u00e9ket<br \/>\n\u2705 Cs\u00f6kkenti a csontveszt\u00e9st<br \/>\n\u2705 Jav\u00edtja az \u00e9letmin\u0151s\u00e9get<\/p>\n<p><strong>Tenvir AF<\/strong> tartalmaz <strong>Tenofovir<\/strong> <strong>Alafenamid<\/strong>.<\/p>","protected":false},"featured_media":60777,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3334,3304],"product_tag":[3335,4920,4921],"class_list":{"0":"post-60776","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-hepatitis-medication","9":"product_cat-hiv-medication","10":"product_tag-tenofovir","11":"product_tag-tenofovir-alafenamide","12":"product_tag-tenvir-af","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/60776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=60776"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/60777"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=60776"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=60776"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=60776"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=60776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}